CORDIS
EU research results

CORDIS

English EN
FAIRplus

FAIRplus

Objective

Wide sharing of knowledge and data drives the progression of science. Shared data allows other researchers to reproduce findings and benchmark quality of experiments. Sharing data so that other researchers can Find, Access and Interoperate – i.e. integrate the data with the outcomes of their own experiments - allows Reuse and an opportunity to build the large aggregated cohorts we need to detect rare signals and manage the many confounding factors in translational research. This project will develop the guidelines and tools needed to make data FAIR. Through worked examples using IMI and EFPIA data and application and extension of existing methods we will improve the level of discovery, accessibility, interoperability and reusability of selected IMI and EFPIA data. In addition, through disseminated guidelines and tailored training for data handlers in academia, SMEs and pharmaceuticals, data management culture will change and be sustained and datasets will be reused by pharmaceutical companies, academia and SMEs. Our FAIR SME & Innovation programme will enable wide data reuse and foster an innovation ecosystem around these data that power future re-use, knowledge generation, and societal benefit. We call this approach ‘FAIRplus’.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Address

Meyerhofstrasse 1
69117 Heidelberg

Germany

Activity type

Research Organisations

EU Contribution

€ 855 638,75

Participants (21)

Sort alphabetically

Sort by EU Contribution

Expand all

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

EU Contribution

€ 326 162,50

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 304 825

THE UNIVERSITY OF MANCHESTER

United Kingdom

EU Contribution

€ 281 417,50

UNIVERSITEIT MAASTRICHT

Netherlands

EU Contribution

€ 258 401,25

SIB INSTITUT SUISSE DE BIOINFORMATIQUE

Switzerland

EU Contribution

€ 191 837,50

UNIVERSITE DU LUXEMBOURG

Luxembourg

EU Contribution

€ 294 037,50

BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION

Spain

EU Contribution

€ 190 306,25

FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM

Spain

EU Contribution

€ 162 383,75

OPEN PHACTS FOUNDATION LBG

United Kingdom

EU Contribution

€ 211 937,50

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom

EU Contribution

€ 235 255

HERIOT-WATT UNIVERSITY

United Kingdom

EU Contribution

€ 70 487,50

STICHTING LYGATURE

Netherlands

EU Contribution

€ 296 511,25

THE HYVE BV

Netherlands

EU Contribution

€ 209 435

UNIVERSITE PAUL SABATIER TOULOUSE III

France

EU Contribution

€ 107 513,75

JANSSEN PHARMACEUTICA NV

Belgium

ASTRAZENECA AB

Sweden

Eli Lilly and Company Limited

United Kingdom

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

United Kingdom

NOVARTIS PHARMA AG

Switzerland

BAYER AKTIENGESELLSCHAFT

Germany

BOEHRINGER INGELHEIM INTERNATIONALGMBH

Germany

Project information

Grant agreement ID: 802750

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    30 June 2022

Funded under:

H2020-EU.3.1.7.

  • Overall budget:

    € 8 228 650

  • EU contribution

    € 3 996 150

Coordinated by:

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany